Literature DB >> 22314810

Is indeterminate colitis determinable?

William J Tremaine1.   

Abstract

About 10% of patients with colitis due to inflammatory bowel disease have indeterminate colitis. Despite newer diagnostic tools, the frequency has not diminished over the past 33 years. The current preferred term among academicians is colonic inflammatory bowel disease unclassified(IBDU), although indeterminate colitis is the term endorsed for inclusion in the ICD-10 coding system. Indeterminate colitis is more frequent among children. Theanti-Saccharomyces cerevisiae (ASCA) and perinuclear anti-cytoplasmic antibody (pANCA) are useful in distinguishing IBDU from ulcerative colitis and Crohn’s disease. However, current serologic and genetic studies, as well as endoscopic and imaging studies lack sufficient positive predictive values to make a definite diagnosis of Crohn’s colitis or ulcerative colitis. Patients with IBDU who undergo proctocolectomy with ileal pouch-anal anastomosis have more complications than patients with ulcerative colitis. Although some patients with indeterminate colitis eventually develop characteristic ulcerative colitis or Crohn’s disease, a subgroup are durably indeterminate.

Entities:  

Mesh:

Year:  2012        PMID: 22314810     DOI: 10.1007/s11894-012-0244-x

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  23 in total

1.  The value of serologic markers in indeterminate colitis: a prospective follow-up study.

Authors:  Sofie Joossens; Walter Reinisch; Séverine Vermeire; Boualem Sendid; Daniel Poulain; Marc Peeters; Karel Geboes; Xavier Bossuyt; Peggy Vandewalle; Georg Oberhuber; Harald Vogelsang; Paul Rutgeerts; Jean-Frédéric Colombel
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

2.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

Authors:  Mark S Silverberg; Jack Satsangi; Tariq Ahmad; Ian D R Arnott; Charles N Bernstein; Steven R Brant; Renzo Caprilli; Jean-Frédéric Colombel; Christoph Gasche; Karel Geboes; Derek P Jewell; Amir Karban; Edward V Loftus; A Salvador Peña; Robert H Riddell; David B Sachar; Stefan Schreiber; A Hillary Steinhart; Stephan R Targan; Severine Vermeire; B F Warren
Journal:  Can J Gastroenterol       Date:  2005-09       Impact factor: 3.522

Review 3.  Indeterminate colitis: a review of the concept--what's in a name?

Authors:  Karel Geboes; Jean-Frédéric Colombel; Adrian Greenstein; Derek P Jewell; William J Sandborn; Morten H Vatn; Bryan Warren; Robert H Riddell
Journal:  Inflamm Bowel Dis       Date:  2008-06       Impact factor: 5.325

4.  What is the incidence, prevalence, and natural history of indeterminate colitis?

Authors:  Gianmichele Meucci
Journal:  Inflamm Bowel Dis       Date:  2008-10       Impact factor: 5.325

5.  Overlap in the spectrum of non-specific inflammatory bowel disease--'colitis indeterminate'.

Authors:  A B Price
Journal:  J Clin Pathol       Date:  1978-06       Impact factor: 3.411

6.  Serologic responses in indeterminate colitis patients before ileal pouch-anal anastomosis may determine those at risk for continuous pouch inflammation.

Authors:  Thomas Hui; Carol Landers; Eric Vasiliauskas; Maria Abreu; Marla Dubinsky; Konstantinos A Papadakis; Joanne Price; Ying-Chao Lin; Yang Huiying; Stephan Targan; Phillip Fleshner
Journal:  Dis Colon Rectum       Date:  2005-06       Impact factor: 4.585

7.  Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort.

Authors:  Rinse K Weersma; Pieter C F Stokkers; Isabelle Cleynen; Simone C S Wolfkamp; Liesbet Henckaerts; Stefan Schreiber; Gerard Dijkstra; Andre Franke; Ilja M Nolte; Paul Rutgeerts; Cisca Wijmenga; Séverine Vermeire
Journal:  Am J Gastroenterol       Date:  2009-01-27       Impact factor: 10.864

8.  Infliximab in the treatment of medically refractory indeterminate colitis.

Authors:  K A Papadakis; L Treyzon; M T Abreu; P R Fleshner; S R Targan; E A Vasiliauskas
Journal:  Aliment Pharmacol Ther       Date:  2003-10-01       Impact factor: 8.171

9.  Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease.

Authors:  William S Mow; Simon K Lo; Stephan R Targan; Marla C Dubinsky; Leo Treyzon; Maria T Abreu-Martin; Konstantinos A Papadakis; Eric A Vasiliauskas
Journal:  Clin Gastroenterol Hepatol       Date:  2004-01       Impact factor: 11.382

Review 10.  Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.

Authors:  A Bourreille; A Ignjatovic; L Aabakken; E V Loftus; R Eliakim; M Pennazio; Y Bouhnik; E Seidman; M Keuchel; J G Albert; S Ardizzone; S Bar-Meir; R Bisschops; E J Despott; P F Fortun; R Heuschkel; J Kammermeier; J A Leighton; G J Mantzaris; D Moussata; S Lo; V Paulsen; J Panés; G Radford-Smith; W Reinisch; E Rondonotti; D S Sanders; J M Swoger; H Yamamoto; S Travis; J-F Colombel; A Van Gossum
Journal:  Endoscopy       Date:  2009-07-08       Impact factor: 10.093

View more
  14 in total

Review 1.  Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease.

Authors:  Anet A Soubières; Andrew Poullis
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

2.  Gastrointestinal endoscopy biopsy derived proteomic patterns predict indeterminate colitis into ulcerative colitis and Crohn's colitis.

Authors:  Billy Ray Ballard; Amosy Ephreim M'Koma
Journal:  World J Gastrointest Endosc       Date:  2015-06-25

Review 3.  Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics.

Authors:  Amosy E M'Koma
Journal:  World J Gastrointest Surg       Date:  2014-11-27

Review 4.  Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives.

Authors:  Gian Eugenio Tontini; Maurizio Vecchi; Luca Pastorelli; Markus F Neurath; Helmut Neumann
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

Review 5.  Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview.

Authors:  Amosy Ephreim M'Koma
Journal:  Medicina (Kaunas)       Date:  2022-04-21       Impact factor: 2.948

6.  Characteristics of inflammatory bowel disease serology in patients with indeterminate colitis.

Authors:  Siddharth P Sura; Awais Ahmed; Adam S Cheifetz; Alan C Moss
Journal:  J Clin Gastroenterol       Date:  2014-04       Impact factor: 3.062

7.  Gene Expression-Genotype Analysis Implicates GSDMA, GSDMB, and LRRC3C as Contributors to Inflammatory Bowel Disease Susceptibility.

Authors:  Jan Söderman; Linda Berglind; Sven Almer
Journal:  Biomed Res Int       Date:  2015-09-21       Impact factor: 3.411

8.  Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn's Colitides.

Authors:  Olga Y Korolkova; Jeremy N Myers; Samuel T Pellom; Li Wang; Amosy E M'Koma
Journal:  Clin Med Insights Gastroenterol       Date:  2015-05-06

9.  An Esophagogastroduodenal Crohn's-Like Disease in a Long-Standing Pan-Ulcerative Colitis Patient.

Authors:  Christopher Moore; Shriram Jakate; Ali Keshavarzian
Journal:  Case Rep Gastrointest Med       Date:  2014-09-10

10.  Plasma microRNA Profile Differentiates Crohn's Colitis From Ulcerative Colitis.

Authors:  Uri Netz; Jane Carter; M Robert Eichenberger; Kayla Feagins; Norman J Galbraith; Gerald W Dryden; Jianmin Pan; Shesh N Rai; Susan Galandiuk
Journal:  Inflamm Bowel Dis       Date:  2017-12-19       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.